$ALC Alcon Completes Acquisition of Aerie Pharmaceuticals, Inc., Strengthening Company’s Ophthalmic Pharmaceutical Business

on November 22, 2022 News and Tags: , , , , , , , with 0 comments
Time:
11:01 PM
Symbol:
ALC
Source:
Business Wire
Read more

$AERI Alcon Completes Acquisition of Aerie Pharmaceuticals, Inc., Strengthening Company’s Ophthalmic Pharmaceutical Business

on November 21, 2022 News and Tags: , , , , , , , with 0 comments
Time:
11:01 PM
Symbol:
AERI
Source:
Read more

$AERI Aerie Pharmaceuticals Reports Third Quarter 2022 Financial Results

on November 3, 2022 News and Tags: , , , with 0 comments
Time:
2:01 PM
Symbol:
AERI
Source:
Business Wire
Read more

$AERI Aerie Pharmaceuticals Reports Third Quarter 2022 Financial Results

on November 3, 2022 News and Tags: , , , with 0 comments
Time:
2:01 PM
Symbol:
AERI
Source:
Read more

$AERI Alcon to Acquire Aerie Pharmaceuticals, Inc., Enhancing its Ophthalmic Pharmaceutical Portfolio

on August 22, 2022 News and Tags: , , , , , , , with 0 comments
Time:
9:18 PM
Symbol:
AERI
Source:
Business Wire
Read more

$AERI Aerie Pharmaceuticals Announces New Employee Inducement Grant

on August 15, 2022 News and Tags: , , , with 0 comments
Time:
6:30 AM
Symbol:
AERI
Source:
Business Wire
Read more

$AERI Aerie Pharmaceuticals Announces First Participant Dosed in the COMET-3 Study of AR-15512 for the Treatment of Dry Eye Disease

on August 1, 2022 News and Tags: , , , with 0 comments
Time:
4:01 PM
Symbol:
AERI
Source:
Business Wire
Read more

$AERI Aerie Pharmaceuticals to Announce Second Quarter 2022 Financial Results and Host Conference Call on Thursday, August 4, 2022 at 5:00 p.m. ET

on July 28, 2022 News and Tags: , , , with 0 comments
Time:
6:10 PM
Symbol:
AERI
Source:
Business Wire
Read more

$AERI Aerie Pharmaceuticals Announces New Employee Inducement Grant

on July 8, 2022 News and Tags: , , , with 0 comments
Time:
6:30 AM
Symbol:
AERI
Source:
Business Wire
Read more

$AERI Aerie Pharmaceuticals to Participate in the Jefferies Healthcare Conference on Friday, June 10, 2022 at 10:30 a.m. ET

on May 25, 2022 News and Tags: , , , with 0 comments
Time:
4:30 PM
Symbol:
AERI
Source:
Business Wire
Read more

$AERI Aerie Pharmaceuticals to Participate in the 21st Annual Needham Virtual Healthcare Conference on Tuesday, April 12, 2022 at 3:00 p.m. ET

on April 6, 2022 News and Tags: , , , with 0 comments
Time:
4:30 PM
Symbol:
AERI
Source:
Business Wire News Releases
Read more

$AERI Aerie Pharmaceuticals Appoints Peter Lang as Chief Financial Officer

on March 18, 2022 News and Tags: , , , with 0 comments
Time:
7:00 AM
Symbol:
AERI
Source:
Business Wire News Releases
Read more

$AERI Aerie Pharmaceuticals to Announce Fourth Quarter and Full Year 2021 Financial Results and Host Conference Call on Thursday, February 24, 2022 at 5:00 p.m. ET

on February 17, 2022 News and Tags: , , , with 0 comments
Time:
4:45 PM
Symbol:
AERI
Source:
Business Wire News Releases
Read more

$AERI Aerie Pharmaceuticals Reports Inducement Grant to Chief Executive Officer Under Nasdaq Listing Rule 5635(c)(4)

on December 22, 2021 News and Tags: , , , with 0 comments
Time:
4:01 PM
Symbol:
AERI
Source:
Business Wire News Releases
Read more

$AERI Aerie Pharmaceuticals Appoints Raj Kannan as Chief Executive Officer

on December 16, 2021 News and Tags: , , , with 0 comments
Time:
6:30 AM
Symbol:
AERI
Source:
Business Wire News Releases
Read more

$AERI Aerie Concludes Exclusive License Agreement With Santen for Rhopressa® and Rocklatan® in Europe and Several Other Regions

on December 7, 2021 News and Tags: , , , with 0 comments
Time:
2:00 AM
Symbol:
AERI
Source:
Business Wire News Releases
Read more

$AERI Aerie Pharmaceuticals to Participate in Upcoming Investor Conferences

on November 9, 2021 News and Tags: , , , with 0 comments
Time:
4:30 PM
Symbol:
AERI
Source:
Business Wire News Releases
Read more

$AERI Aerie Pharmaceuticals to Announce Third Quarter 2021 Financial Results and Host Conference Call on Thursday, November 4, 2021

on October 28, 2021 News and Tags: , , , with 0 comments
Time:
7:30 AM
Symbol:
AERI
Source:
Business Wire News Releases
Read more

$AERI Aerie Pharmaceuticals Announces Presentation at the Ophthalmology Innovation Summit Glaucoma Innovation Showcase

on October 21, 2021 News and Tags: , , , with 0 comments
Time:
4:01 PM
Symbol:
AERI
Source:
Business Wire News Releases
Read more

$AERI Aerie Pharmaceuticals Announces Positive Phase 3 Topline Results for Netarsudil Ophthalmic Solution 0.02% Clinical Trial in Japan

on October 12, 2021 News and Tags: , , , with 0 comments
Time:
6:30 AM
Symbol:
AERI
Source:
Business Wire News Releases
Read more